PH18297A - 1-phenyl-2(h,3h)endolone psychotherapeutic agents - Google Patents

1-phenyl-2(h,3h)endolone psychotherapeutic agents

Info

Publication number
PH18297A
PH18297A PH29565A PH29565A PH18297A PH 18297 A PH18297 A PH 18297A PH 29565 A PH29565 A PH 29565A PH 29565 A PH29565 A PH 29565A PH 18297 A PH18297 A PH 18297A
Authority
PH
Philippines
Prior art keywords
phenyl
indolones
treatment
endolone
psychotherapeutic agents
Prior art date
Application number
PH29565A
Other languages
English (en)
Inventor
Harry Ralph Howard Jr
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH18297A publication Critical patent/PH18297A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH29565A 1982-09-20 1983-09-20 1-phenyl-2(h,3h)endolone psychotherapeutic agents PH18297A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,544 US4476307A (en) 1982-09-20 1982-09-20 Heteroylidene indolone compounds

Publications (1)

Publication Number Publication Date
PH18297A true PH18297A (en) 1985-05-24

Family

ID=23666904

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29565A PH18297A (en) 1982-09-20 1983-09-20 1-phenyl-2(h,3h)endolone psychotherapeutic agents

Country Status (24)

Country Link
US (1) US4476307A (2)
EP (1) EP0104860B1 (2)
JP (1) JPS5976058A (2)
KR (1) KR860001270B1 (2)
AT (1) ATE25972T1 (2)
AU (1) AU543115B2 (2)
CA (1) CA1194871A (2)
DD (1) DD213211A5 (2)
DE (1) DE3370325D1 (2)
DK (1) DK157010C (2)
ES (3) ES8503328A1 (2)
FI (1) FI77446C (2)
GR (1) GR79732B (2)
HU (1) HU189747B (2)
IE (1) IE55923B1 (2)
IL (1) IL69758A (2)
NO (1) NO161557C (2)
NZ (1) NZ205638A (2)
PH (1) PH18297A (2)
PL (3) PL141370B1 (2)
PT (1) PT77360B (2)
SU (1) SU1272983A3 (2)
YU (4) YU189283A (2)
ZA (1) ZA836933B (2)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5128352A (en) * 1989-01-10 1992-07-07 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
US5078756A (en) * 1990-01-12 1992-01-07 Major Thomas O Apparatus and method for purification and recovery of refrigerant
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5760250A (en) * 1991-11-05 1998-06-02 Zeneca Limited Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
DE19949209A1 (de) * 1999-10-13 2001-04-19 Boehringer Ingelheim Pharma In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US20030225152A1 (en) * 2001-09-27 2003-12-04 Andrews Steven W. 3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
US20050101788A1 (en) * 2002-03-27 2005-05-12 Jacopo Zanon Method for manufacture of sertindole
FR2847811B1 (fr) * 2002-11-29 2005-01-07 Oreal Composition filtrante contenant au moins un derive du dibenzoylmethane et au moins un derive de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one;procede de photostabilisation
FR2847813A1 (fr) * 2002-11-29 2004-06-04 Oreal Compositions cosmetiques photoprotectrices contenant des derives de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one et utilisations
MX2007014114A (es) 2005-05-10 2008-03-14 Intermune Inc Derivados de piridona para modular el sistema de proteina cinasa activada por estres.
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン, インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
JP5390535B2 (ja) 2008-12-19 2014-01-15 日本曹達株式会社 1−ヘテロジエン誘導体および有害生物防除剤
KR101376443B1 (ko) 2009-11-12 2014-03-19 닛뽕소다 가부시키가이샤 1-헤테로디엔 유도체 및 유해 생물 방제제
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506683A (en) * 1963-10-07 1970-04-14 Upjohn Co 3-(2-pyrrolidinylidene)-3h-indoles
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
US3723457A (en) * 1969-09-30 1973-03-27 Eisai Co Ltd Indoline-2-one derivatives and preparation thereof
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
DE2557342A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR860001270B1 (ko) 1986-09-04
GR79732B (2) 1984-10-31
US4476307A (en) 1984-10-09
JPS6241711B2 (2) 1987-09-04
ES8505951A1 (es) 1985-06-01
ES531908A0 (es) 1985-06-01
PL250769A1 (en) 1985-07-02
DK157010B (da) 1989-10-30
FI77446C (fi) 1989-03-10
ES8505950A1 (es) 1985-06-01
PT77360B (en) 1986-05-19
YU169386A (en) 1987-10-31
EP0104860A1 (en) 1984-04-04
CA1194871A (en) 1985-10-08
IE55923B1 (en) 1991-02-27
AU1925283A (en) 1984-03-29
DD213211A5 (de) 1984-09-05
ES525737A0 (es) 1985-02-16
PL141370B1 (en) 1987-07-31
NZ205638A (en) 1986-12-05
KR840006239A (ko) 1984-11-22
NO161557C (no) 1989-08-30
YU169186A (en) 1987-10-31
ES531907A0 (es) 1985-06-01
DK157010C (da) 1990-03-26
IE832193L (en) 1984-03-20
IL69758A (en) 1986-12-31
PL243826A1 (en) 1985-04-24
JPS5976058A (ja) 1984-04-28
YU189283A (en) 1987-10-31
AU543115B2 (en) 1985-04-04
FI833335A0 (fi) 1983-09-19
HU189747B (en) 1986-07-28
YU169286A (en) 1987-10-31
ES8503328A1 (es) 1985-02-16
ATE25972T1 (de) 1987-04-15
PT77360A (en) 1983-10-01
EP0104860B1 (en) 1987-03-18
NO161557B (no) 1989-05-22
PL141876B1 (en) 1987-09-30
SU1272983A3 (ru) 1986-11-23
DK425383D0 (da) 1983-09-19
FI833335A7 (fi) 1984-03-21
IL69758A0 (en) 1983-12-30
DK425383A (da) 1984-05-03
PL250768A1 (en) 1985-07-02
PL141609B1 (en) 1987-08-31
ZA836933B (en) 1985-05-29
FI77446B (fi) 1988-11-30
NO833367L (no) 1984-03-21
DE3370325D1 (en) 1987-04-23

Similar Documents

Publication Publication Date Title
YU189283A (en) 1-phenyl-2(1h,3h)-indolonic psychotherapeutic means
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
GB9503601D0 (en) Method of treatment and method of manufacture of medicament
ATE40365T1 (de) 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung.
YU1097A (sh) 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni
ZA951295B (en) 6-substituted mycophenolic acid and derivatives
DK0500773T3 (da) Ikke-glycosyleret FGF-4 og præparater indeholdende dette
DE3889974D1 (de) Pyrazol-Derivate und diese enthaltende Behandlungsmittel für cerebrovaskulare Krankheiten.
DE69034209D1 (de) 2'-deoxy-4'-thioribonucleoside als antivirale und antikrebsmittel
ATE20519T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin.
FR2708610B1 (fr) Dérivés du carboxyméthylidènecycloheptimidazole, méthode pour leur fabrication et agents thérapeutiques les contenant.
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
FR2698000B1 (fr) Table d'hydromassage.
ATE112288T1 (de) Vinylsulfonyl pristinamycine und deren herstellung.
DK0833638T3 (da) Anvendelse af imidazo[1,5-a]quinoloner som neuroprotektive midler
IT8921745A0 (it) Sussidio didattico interattivo per lo studio e l'apprendimento di nozioni geo politiche e storiche, lingue e simili.
ITMO940015V0 (it) Leggio modulare per la consultazione di cataloghi e simili da parte dipiu' utenti contemporaneamente.
IT1263076B (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.